These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 37410921

  • 1. The current and future burden of hepatitis B in Switzerland: a modelling study.
    Negro F, Müllhaupt B, Semela D, Blach S, Bruggmann P, De Gottardi A, Dufour JF, Fraga M, Galante A, Razavi H, Vieira Barbosa J, Razavi-Shearer D.
    Swiss Med Wkly; 2023 Jun 05; 153():40086. PubMed ID: 37410921
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    GBD 2019 Hepatitis B Collaborators.
    Lancet Gastroenterol Hepatol; 2022 Sep 05; 7(9):796-829. PubMed ID: 35738290
    [Abstract] [Full Text] [Related]

  • 4. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS.
    Int J Epidemiol; 2005 Dec 05; 34(6):1329-39. PubMed ID: 16249217
    [Abstract] [Full Text] [Related]

  • 5. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study.
    Polaris Observatory Collaborators.
    Lancet Gastroenterol Hepatol; 2018 Jun 05; 3(6):383-403. PubMed ID: 29599078
    [Abstract] [Full Text] [Related]

  • 6. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH, Chen DS.
    Pathol Biol (Paris); 2010 Aug 05; 58(4):296-300. PubMed ID: 20116181
    [Abstract] [Full Text] [Related]

  • 7. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.
    Nguyen VT, Law MG, Dore GJ.
    Liver Int; 2008 Apr 05; 28(4):525-31. PubMed ID: 18266635
    [Abstract] [Full Text] [Related]

  • 8. Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
    Vieira Barbosa J, Sahli R, Aubert V, Chaouch A, Moradpour D, Fraga M.
    PLoS One; 2021 Apr 05; 16(4):e0250347. PubMed ID: 33905426
    [Abstract] [Full Text] [Related]

  • 9. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia.
    Sanai FM, Alghamdi M, Dugan E, Alalwan A, Al-Hamoudi W, Abaalkhail F, AlMasri N, Razavi-Shearer D, Razavi H, Schmelzer J, Alfaleh FZ.
    J Infect Public Health; 2020 Nov 05; 13(11):1715-1723. PubMed ID: 32988769
    [Abstract] [Full Text] [Related]

  • 10. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
    Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Robbins Scott S, Semela D, Negro F.
    PLoS One; 2018 Nov 05; 13(12):e0209374. PubMed ID: 30596701
    [Abstract] [Full Text] [Related]

  • 11. Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model.
    Mohareb AM, Kim AY, Boyd A, Noubary F, Kouamé MG, Anglaret X, Coffie PA, Eholie SP, Freedberg KA, Hyle EP.
    BMJ Open; 2024 Jan 12; 14(1):e073498. PubMed ID: 38216186
    [Abstract] [Full Text] [Related]

  • 12. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ, Kreuels B, Henrion MYR, Giorgi E, Kyomuhangi I, de Martel C, Hutin Y, Geretti AM.
    J Hepatol; 2020 Sep 12; 73(3):523-532. PubMed ID: 32335166
    [Abstract] [Full Text] [Related]

  • 13. Perspectives and control of hepatitis B virus infection in Taiwan.
    Lin CL, Kao JH.
    J Formos Med Assoc; 2015 Oct 12; 114(10):901-9. PubMed ID: 26184565
    [Abstract] [Full Text] [Related]

  • 14. Natural history of chronic hepatitis B REVEALed.
    Chen CJ, Yang HI.
    J Gastroenterol Hepatol; 2011 Apr 12; 26(4):628-38. PubMed ID: 21323729
    [Abstract] [Full Text] [Related]

  • 15. Chronic hepatitis B virus infection in Asian countries.
    Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.
    J Gastroenterol Hepatol; 2000 Dec 12; 15(12):1356-61. PubMed ID: 11197043
    [Abstract] [Full Text] [Related]

  • 16. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
    Songtanin B, Chaisrimaneepan N, Mendóza R, Nugent K.
    Viruses; 2024 Apr 16; 16(4):. PubMed ID: 38675959
    [Abstract] [Full Text] [Related]

  • 17. NIH consensus development statement on management of hepatitis B.
    Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Sorrell MF, Strader DB, Trotter HT.
    NIH Consens State Sci Statements; 2024 Apr 16; 25(2):1-29. PubMed ID: 18949020
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures.
    Lavanchy D.
    J Viral Hepat; 2004 Mar 16; 11(2):97-107. PubMed ID: 14996343
    [Abstract] [Full Text] [Related]

  • 19. Feasibility of hepatitis B elimination in high-income countries with ongoing immigration.
    Tian F, Feld JJ, Feng Z, Sander B, Wong WWL.
    J Hepatol; 2022 Oct 16; 77(4):947-956. PubMed ID: 35483535
    [Abstract] [Full Text] [Related]

  • 20. Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.
    Ive P, MacLeod W, Mkumla N, Orrell C, Jentsch U, Wallis CL, Stevens W, Wood R, Sanne I, Bhattacharya D.
    PLoS One; 2013 Oct 16; 8(12):e74900. PubMed ID: 24324573
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.